Bortezomib (PS-341, Velcade) increases the efficacy of trastuzumab (Herceptin) in HER-2-positive breast cancer cells in a synergistic manner.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples